The Denosumab And Teriparatide Administration Study (DATA)

Trial Profile

The Denosumab And Teriparatide Administration Study (DATA)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 01 May 2017

At a glance

  • Drugs Denosumab (Primary) ; Teriparatide (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Biomarker; Therapeutic Use
  • Acronyms DATA; DATA-Switch
  • Most Recent Events

    • 01 May 2017 Results (n=50) assessing importance of consolidation therapy in postmenopausal women discontinuing teriparatide or denosumab, published in the Bone
    • 30 Nov 2016 Planned End Date changed from 1 Feb 2016 to 1 Dec 2016.
    • 30 Nov 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top